Location History:
- San Clemente, CA (US) (1991)
- Hackensack, NJ (US) (2021)
- San Juan Capistrano, CA (US) (1997 - 2023)
Company Filing History:
Years Active: 1991-2025
Title: Innovations in Drug Delivery: The Contributions of Jeffrey Alan Klein
Introduction: Jeffrey Alan Klein, based in San Juan Capistrano, CA, is a prolific inventor with an impressive portfolio of 33 patents. His work primarily focuses on enhancing drug delivery systems, particularly through tumescent infiltration techniques, which have significant applications in chemotherapy and other therapeutic arenas.
Latest Patents: Among his latest patents is a groundbreaking innovation titled "Tumescent infiltration drug delivery of high subcutaneous drug concentrations with prolonged local and systemic effects and minimal local or systemic toxicity." This invention outlines a tumescent composition that comprises a chemotherapy agent designed to hold specific concentrations that optimize therapeutic effects while minimizing toxicity. The tumescent solution includes a vasoconstrictor, a pharmaceutically acceptable carrier, and may optionally contain a local anesthetic, maintaining a balance between efficacy and safety.
Another notable patent by Klein is similar in nature but focuses on a broader range of therapeutic agents. This invention also details a tumescent composition that ensures the delivery of drugs in a safe yet effective manner, further solidifying Klein's contributions to advancing drug delivery technologies.
Career Highlights: Klein has demonstrated remarkable expertise in pharmacological innovations. His substantial body of work has paved the way for more effective therapeutic approaches, particularly in cancer treatment. His ability to merge clinical safety with innovative drug delivery systems places him at the forefront of pharmaceutical research and development.
Collaborations: Throughout his career, Klein has collaborated with various professionals, including notable individuals such as Paytra Alan Klein and Bram Alan Klein, enriching his insights and expanding the potential of his inventions in the medical field.
Conclusion: Jeffrey Alan Klein's innovative contributions to drug delivery systems showcase the impact of research and ingenuity in healthcare. His patents not only address critical challenges in medicine but also illustrate the importance of collaboration and innovation in developing effective treatment methodologies. As a respected inventor, Klein continues to inspire advancements that enhance patient care and outcomes.